BBC News video: Why cancer patients are flying to China for treatment – Australian MD seek cancer treatments in China and was successful cost US$64,000. Same treatments in US, Canada & EU would cost 10x more or US$640,000 and it would takes much longer! BBC新聞影片有中英文字幕：為何癌症病患飛往中國求醫 – 澳洲一名醫生赴中國尋求癌症治療，結果成功治癒，花費6萬4千美元。同樣的療程在美國、加拿大及歐盟，費用會高出10倍，達到64萬美元，而且等待時間也會長得多!
https://rumble.com/v7c70fc-why-cancer-patients-are-flying-to-china-for-treatment.html
https://www.tiktok.com/t/ZP8GD81hh/
https://m.facebook.com/story.php?story_fbid=pfbid02uUAosHE3cwHhMXuouDhTLXDM7pXn8tEDo7hVBc8h3HwVsNHHU9DVYDyyFR3GYcgVl&id=100036400039778&mibextid=wwXIfr
中國正崛起為醫療旅遊目的地，提供尖端的CAR-T細胞療法，其速度更快、價格更低，且比許多西方國家更容易獲得。
多年來，亞洲的醫療旅遊一向與泰國、南韓等目的地畫上等號。
但如今，愈來愈多病患前往中國尋求先進癌症治療，費用往往僅是他們本國的一小部分。
中國正迅速開發新型CAR-T細胞療法，這是一種透過改造患者免疫細胞，使其更有效地發現並攻擊癌細胞的治療方式。
該療法最初在美國研發，主要用於化療等一線治療後仍復發的血液癌症。
中國現今在CAR-T細胞療法的臨床試驗數量上領先全球，其生技公司也已開發出能大幅加快療程進度的方法。
在本集Asia Specific中，主持人Mariko Oi訪談了Amanda Harvey——一位澳洲籍患者同時也是醫師，她在接受多輪多發性骨髓瘤化療後，前往上海接受CAR-T療法。
Mariko也邀請到彭博社健康記者Karoline Kan，她一直報導中國在先進醫療照護方面日益增長的聲譽，一同探討中國如何成為CAR-T療法的領導者、為何治療費用能便宜這麼多，以及中國是否能在未來幾年間成為主要的醫療旅遊樞紐。
本播客討論癌症治療與患者經驗，僅供參考。內容不應視為醫療建議。若您對自身健康或治療選項有疑慮，請尋求合格醫療專業人員的指導。
China is emerging as a medical tourism destination offering cutting-edge CAR-T cell therapy that can be faster, cheaper and more accessible than many Western countries.
For years, Asian medical tourism has been associated with destinations such as Thailand and South Korea.
But a growing number of patients are now travelling to China for advanced cancer treatment, often at a fraction of the cost than in their home countries.
China is rapidly developing new CAR-T cell therapies, a type of treatment that involves modifying a patient’s immune cells to find and attack cancer cells more effectively.
Originally developed in the United States, the therapy has primarily been used for blood cancers that return despite frontline treatments like chemotherapy.
China now leads the world in the number of CAR T-cell clinical trials and its biotech companies have developed ways to rapidly speed up the process.
In this episode of Asia Specific, host Mariko Oi speaks to Amanda Harvey, an Australian patient and doctor who travelled to Shanghai for CAR-T therapy after several rounds of chemotherapy treatment for multiple myeloma.
Mariko is also joined by Bloomberg Health reporter Karoline Kan, who has been reporting on China’s growing reputation for advanced medical care to discuss how China became a leader in CAR-T therapy, why treatment can be much cheaper, and whether China could become a major medical tourism hub in the years ahead.
This podcast discusses cancer treatment and patient experiences and is for information only. It should not be considered medical advice. If you have concerns about your health or treatment options, please seek guidance from a qualified healthcare professional.
Johnson Choi Biz 